Non-invasive, Real-time Anesthetic Drug-monitoring System

Rambam Health Care Campus30 enrolled

Overview

The aim of this study is to determine efficacy of the "CorrecDose" device to continuously and non-invasively follow the changes in propofol concentrations in the participants' blood.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Anesthesia

Interventions

CorrecDose Infrared MonitorDEVICE

The monitor is attached to patient's wrist and ear in order to measure changes in propofol concentrations in blood

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Women who have signed Informed consent form * Women undergoing Trans vaginal ovum retrieval (TVOR) for invitro fertilization (IVF) and will be sedated with propofol administered intravenos (IV) Exclusion Criteria: * Women with background diseases * Women with chronic use of drug and medication * Women with peripheral blood vessels problems * Women with high blood pressure * Women with body mass index (BMI) score over 35 or less than 18

Outcomes

Primary Outcomes

Changes in Propofol Blood Levels

Graphic display on monitor of real-time changes

Time frame: Half hour

Central Contacts

Philippe Abecassis, MD

CONTACT

+972502061058 p_abecassis@rambam.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.